Navigation Links
OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center
Date:7/23/2014

Plainsboro, N.J. (PRWEB) July 23, 2014

OncLive® is pleased to announce that UNC Lineberger Comprehensive Cancer Center has joined its Strategic Alliance Partnership program.

By participating in the Strategic Alliance Partnership program, UNC Lineberger will have the opportunity to work with the OncLive team to raise awareness of its cutting-edge research initiatives, community-directed cancer prevention programs, and other projects. Experts from UNC Lineberger will work with OncLive to educate their peers by providing insights and analysis on the latest news and discoveries in oncology.

UNC Lineberger is a National Cancer Institute-designated comprehensive cancer center, one of only 41 such organizations in the country, and has been providing multidisciplinary, patient-centered care for more than a quarter century. The clinicians and researchers at UNC Lineberger have also been at the forefront of applying advanced technologies such as Intensity Modulated Radiation therapy, Intraoperative Radiation Therapy, and robotic surgery in the treatment of cancer.

In addition to leading important cancer epidemiology and cancer prevention and control programs that examine patterns of cancer in the community to understand the complex interaction among genetics, biology, environmental exposures and behaviors that cause cancer, UNC Lineberger researchers and clinicians also run research programs in Cancer Cell Biology, Immunology, Molecular Carcinogenesis, Cancer Genetics, Molecular Therapeutics, and Virology that investigate the molecular and genetic basis of cancer and progression.

Mike Hennessy, Jr., Vice President of Sales and Marketing and leader of the oncology division of Intellisphere, the publisher of OncLive, said, “UNC Lineberger Comprehensive Cancer Center is an internationally recognized and respected leader in comprehensive cancer research, treatment, and support. We are excited and honored to partner with them to support their mission of reducing cancer occurrence and death through research, treatment, training, and outreach.”

To date, more than 20 cancer centers, nursing schools, and other groups have joined OncLive’s Strategic Alliance Partnership program.

To learn more about OncLive®, visit http://www.OncLive.com.

###

About OncLive®
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive® and its family of publications is to provide oncology professionals with the resources and information they need in order to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of health care publishing, research, and education. To learn more, please visit http://www.OncLive.com.

About UNC Lineberger Comprehensive Cancer Center
One of only 41 NCI-designated comprehensive cancer centers, the University of North Carolina Lineberger Comprehensive Cancer Center brings together some of the most exceptional physicians and scientists in the country to investigate and improve the prevention, early detection and treatment of cancer. With research that spans the spectrum from the laboratory to the bedside to the community, UNC Lineberger faculty work to understand the causes of cancer at the genetic and environmental levels, to conduct groundbreaking laboratory research, and to translate findings into pioneering and innovative clinical trials. For more information, please visit http://www.unclineberger.org.

Media Contact:
Courtney Dysart
For OncLive
267-932-8760 (Office)
courtney(at)hornercom(dot)com

Read the full story at http://www.prweb.com/releases/2014/07/prweb12039203.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Yale Cancer Center Joins OncLive's Strategic Alliance Partnership
2. Particle Sciences Expands Biopharmaceutical Development Infrastructure
3. Ajinomoto Group Expands Cysteine Derivatives Production Capacity
4. Terascala Expands Executive Team
5. Spark Therapeutics Expands Leadership Team to Support Development and Commercialization of its Late-Stage Gene Therapy Pipeline
6. 5W Public Relations Expands Corporate Practice, Adds PURE Bioscience, Inc. to Client Roster
7. Rubicon Genomics Expands Distribution in Europe and Asia
8. SoundConnect Expands Distribution of Adobe Connect Event Module
9. New Monol Oligomer Technology Expands Applications for Cray Valley’s Krasol Additives
10. Edison Expands its European Pharmaceutical Coverage by Initiating on MagForce
11. ImaginAb Expands Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, Inc. has received ... SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. The adjunctive seizure ... periods of rest. A lightweight, non-invasive monitor is placed on the belly of ...
(Date:2/23/2017)...  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing ... that Linda Marbán, Ph.D, president and chief executive officer, is ... Cowen and Company 37th Annual Health Care Conference ... Boston, MA 29th Annual ROTH ... pm ET) Dana Point, CA ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... -- It sounds simple and harmless—an electronic sensor attached ... and alerts parents on their smart phones if, ... But pediatric experts argue that such devices may ... of medical benefits, especially to healthy babies. ... of healthy babies, promising peace of mind about ...
Breaking Biology News(10 mins):